Dr. Michael James Sichlau, MD

Dr. Sichlau practices at Vascular and Interventional Professionals in Hinsdale, Illinois.

Dr. Sichlau's NPI, 1710927793, was assigned on June 7, 2006. Dr. Sichlau graduated from Northwestern University Feinberg Medical School in 1994. Dr. Sichlau holds Illinois license 036097595.

Dr. Sichlau's primary practice is Vascular and Interventional Professionals, at 911 N Elm St, Hinsdale, IL 60521 in Dupage County. The practice phone is (630) 856-7460.

Dr. Sichlau's primary practice is Vascular and Interventional Professionals in Hinsdale, Illinois. Dr. Sichlau is also affiliated with UChicago Medicine AdventHealth Hinsdale. The medical group on file is Vascular and Interventional Professionals. Dmand AI also links Dr. Sichlau to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sichlau practices, 8 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Sichlau's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Sichlau is licensed in Illinois.

CMS data shows 2,449 Medicare services from Dr. Sichlau across 18 procedure codes in 2024, for 382 Medicare patients. Medicare paid $139,413 for them.

CMS counts 382 Medicare patients who saw Dr. Sichlau in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sichlau's median patient age at 70, with 44% women.

In 2024, Dr. Sichlau wrote 104 Medicare Part D claims for 42 patients. 96% of them were for generic drugs. CMS names the drug for 70 of them, across 3 drugs with 11 or more claims each, at $244 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

Dr. Sichlau accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Sichlau, published from 2011 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Iliac Vein, Pelvic Pain and Chronic Pain. Dr. Sichlau has published most often in Phlebology. Dr. Sichlau's most frequent co-authors are Brenda N. Chen, PA-C, Peter Rowe, MD and Luke E. Sewall, MD.

Dmand AI links Dr. Sichlau to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Postthrombotic Syndrome and Venous Insufficiency.

CMS Open Payments shows 180 general payments to Dr. Sichlau from 40 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. BTG International, Inc. paid the most, $24,594.

Dr. Sichlau graduated from Northwestern University Feinberg Medical School in 1994.